Go Pro

Hassan Al-Wakeel Analyst Performance

Analyst at Barclays

Hassan Al-Wakeel is a stock analyst at Barclays in the healthcare sector, covering 3 publicly traded companies. Over the past year, Hassan Al-Wakeel has issued 1 stock ratings, including and sell recommendations. While full access to Hassan Al-Wakeel's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Hassan Al-Wakeel's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
3 Last 4 Years
Buy Recommendations
0.00% 0 Buy Ratings
Companies Covered
3 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy0.0%0 ratings
Hold33.3%1 ratings
Sell66.7%2 ratings

Out of 3 total stock ratings issued by Hassan Al-Wakeel at Barclays, the majority (66.7%) have been Sell recommendations, followed by 33.3% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
66.7% of companies on NYSE
2 companies
OTCMKTS
33.3% of companies on OTCMKTS
1 company

Hassan Al-Wakeel, an analyst at Barclays, currently covers 3 companies listed on NYSE and OTCMKTS, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Healthcare
3 companies
100.0%

Hassan Al-Wakeel of Barclays specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
HEALTHCARE EQUIPMENT & SUPPLIES
2 companies
66.7%
HEALTHCARE PROVIDERS & SERVICES
1 company
33.3%

Hassan Al-Wakeel's Ratings History at Barclays

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
8/5/2026Downgrade$30.48Underweight